Johnson & Johnson (JNJ) News Headlines

▮ More

Date

Headline

9/16/2019 3:48:58 AM OxyContin Maker Purdue Pharma Files For Bankruptcy Protection

9/10/2019 9:02:43 AM Johnson & Johnson To Present At MS Conference; Webcast At 10:00 AM ET

9/5/2019 8:44:46 AM Johnson & Johnson To Present At Wells Fargo Conference; Webcast At 9:45 AM ET

9/5/2019 6:29:46 AM Johnson & Johnson To Present At Barclays Global Conference; Webcast At 7:30 AM

9/4/2019 9:35:01 AM EU Okays Expanded Use Of Janssen's STELARA

8/27/2019 7:18:47 AM J2 Global Unit Acquires BabyCenter From Johnson & Johnson - Quick Facts

8/27/2019 7:06:25 AM Everyday Health Group Buys BabyCenter

8/26/2019 5:57:28 PM Johnson & Johnson Ordered To Pay $572 Million For Oklahoma Opioid Crisis

8/26/2019 5:54:48 PM Johnson & Johnson To Appeal Flawed Opioid Judgment In Oklahoma

8/26/2019 6:47:29 AM Biotech Stocks Facing FDA Decision In September 2019

7/26/2019 7:47:39 AM Janssen Gets CHMP Positive Opinion For Stelara - Quick Facts

7/26/2019 7:18:17 AM Janssen Receives CHMP Positive Opinion For Stelara

7/26/2019 1:55:03 AM Janssen's Late-stage Study On Relapsing Multiple Sclerosis Meets Primary Goal

7/23/2019 9:14:49 AM Opioid Crisis: Trials As Well As Tribulations

7/16/2019 1:35:06 PM Judge To Weigh $17 Bln Opioid Case Against Johnson & Johnson

7/16/2019 7:30:04 AM Johnson & Johnson Q2 19 Earnings Conference Call At 8:30 AM ET

7/16/2019 6:57:32 AM Johnson & Johnson Boosts FY19 Sales Outlook - Quick Facts

7/16/2019 6:48:00 AM Johnson & Johnson (JNJ) Has Raised Its FY20 Revenue Estimate To $82.4 to $83.2 Bln From $82.0 to $82.8 Bln

7/16/2019 6:46:35 AM Johnson & Johnson Q2 adjusted earnings Beat Estimates

7/16/2019 6:41:02 AM Johnson & Johnson Posts Q2 EPS Of $2.08; Adj EPS Of $2.58